WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

CLINICAL EVALUATION OF VIDANGADI PRADEHA & ARAGVADHADI UDVARTANA IN EK-KUSHTHA (PSORIASIS)

Dr. Vijay Kumar*, Dr. Shrimant G. Chavan, Dr. Arvind Gupta and Dr. Shashi Prabha

.

Abstract

Ek-Kushtha is a kind of Kshudra Kushtha that resembles Psoriasis in its clinical presentations and is primarily caused by an imbalance of the Vata and Kapha doshas. It bears a greater resemblance with Psoriasis, which is a long-lasting autoimmune and chronic inflammatory skin disorder clinically characterized by erythematous, sharply demarcated papules and rounded plaques, covered by silvery micaceous scale predominantly affecting the skin of elbows, knees, gluteal cleft, and scalp. Some people may have severe Psoriasis is involving their entire body. The quality of life of patient with Psoriasis is often diminished because of the appearance of skin. The mainstays of psoriasis treatment include immune system suppressing drugs like methotrexate, PUVA, vitamin D3 lotion, and steroid creams. Some contemporary therapeutic methods do have serious drawbacks, particularly when used for an extended period of time. These modern treatment modalities are not devoid from grave complications mainly in long term use. Hence there is a need of Ayurvedic management to cure the Ek-Kushta. In the present research “CLINICAL EVALUATION OF VIDANGADI PRADEHA & ARAGVADHADI UDVARTANA IN EK-KUSHTHA (PSORIASIS)” has been evaluated which is free from the above mentioned drawbacks. Total 40 patients were taken and randomly divided into two equal groups. Group A: Treated group with Vidangadi Pradeha for local application Group B: Treated group with Aragvadhadi Udvartana for local application Out of which the overall effect obtained in Group A (Vidangadi Pradeha) shows that out of 20 patients, and all patients were markedly improved in Group B (Aragvadhadi Udvartana) shows that out of 20 Patients, and all patients were markedly improved without any complication. Result was observed on the basis of subjective parameters and analysed statistically. Although Vidangadi pradeha and Aragvadhadi udvartana both are effective in curing patients suffering with Ek-Kushtha (Psoriasis), but on the basis of overall effect of therapy it was found that Aragvadhadi Udvartana had better result than Vidangadi Pradeha. More over, both therapy were well accepted by all patients and did not produce any side effect during study period. Psoriasis as Ek-kushtha and Ayurvedic management was planned accordingly. Patients were assessed on the basis of clinical symptoms of Ek-Kushtha (as mentioned in Charaka Chikitsa 7) as well as PASI score.

Keywords: Psoriasis; Ek-Kushtha; Panchkarma.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More